Clinical Trial Update: Treat and Extend Analysis Trial With Aflibercept in Wet-AMD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for treat-and-extend analysis with aflibercept in wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Michel Giunta | Conditions: Wet Age-related Macular Degeneration | Phase 3 | Status: UNKNOWN